vancomycin has been researched along with cem 101 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Deng, Q; Wang, Y; Wang, Z; Wen, Z; Xiong, Y; Xu, G; Yu, Z; Zheng, J | 1 |
2 other study(ies) available for vancomycin and cem 101
| Article | Year |
|---|---|
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation.
Topics: Anti-Bacterial Agents; Biofilms; China; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Linezolid; Macrolides; Microbial Sensitivity Tests; Triazoles; Vancomycin | 2021 |